ClinicalTrials.Veeva

Menu

Mollii - Personalized Suit for Treatment of Spasticity, GFMCS 3-5

H

Hvidovre University Hospital

Status

Completed

Conditions

Spastic Cerebral Palsy

Treatments

Device: TENS incorporated into the Mollii suit

Study type

Interventional

Funder types

Other

Identifiers

NCT04322825
H-17004467

Details and patient eligibility

About

The objective of this study was to examine the effect on spasticity and function of multifocal transcutaneous electrical stimulation incorporated in a 2-piece (Mollii) suit.

Full description

In this prospective cohort study, the participants (children with predominantly spastic CP, GFMCS 3-5) wore the suit for 1 hour every second day for 24 weeks. The investigators evaluated level of spasticity using the modified Ashworth scale (MAS) and other related measures before initiation, after 4, 12, and 24 weeks. Two motor related smart goals were defined and evaluated by the goal attainment scale (GAS). GMFM-66 and posture and postural ability scale (PPAS) were performed.

Enrollment

31 patients

Sex

All

Ages

4 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cerebral palsy with spastic disease, GMFCS 3-5.

Exclusion criteria

  • other disorders affecting the sensorimotor functions without spasticity,
  • implanted electric medical devices,
  • BMI>35
  • other severe concomitant diseases such as cancer, cardiovascular, inflammatory, psychiatric disease, medical dysregulated epilepsy or hypertension.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

31 participants in 1 patient group

intervention
Experimental group
Description:
24 weeks of TENS
Treatment:
Device: TENS incorporated into the Mollii suit

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems